The Annual Scientific Meeting of the Canadian Society of Transplantation and the XXIII International Congress of The Transplantation Society
Vancouver, Canada from August 15-19, 2010
The Division of Nephrology and Hypertension, Department of Medicine and The Department of Transplantation Medicine and Extracorporeal Therapy
were well represented at the Annual Scientific meeting of the Canadian Society of Transplantation and the XXIII International Congress of The Transplantation Society.
Dr. M. Suthanthiran, Chief of Nephrology and Hypertension and Transplant Medicine delivered the Andrew Lazarovitz Lecture at the plenary session of the Canadian Society of Transplantation. He also delivered the plenary lecture entitled "Monitoring Allograft Status in the 21st Century: A Noninvasive Molecular Approach" in the opening session of the XXIII International Congress of the Transplantation Society.
Another notable distinction was the awarding of the Transplantation Society/Astellas Young Investigator Award to Dr. Cheguevara Afaneh, a surgery resident performing research in the Suthanthiran laboratory, in recognition of Dr. Afaneh's research presentation entitled "Differential regulation of positive or negative costimulatory molecules during acute rejection of human renal allografts".
The presentations at the Congress were:
Molecular Diagnostics: Ready for Prime Time?
M. Suthanthiran
How to Get Your Paper Published
M. Suthanthiran
Monitoring Allograft Status in the 21st Century: A Noninvasive Molecular Approach
M. Suthanthiran
Systemic TGF-beta1 Gene Therapy Induces Foxp3+ Regulatory T Cells and Delays the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
H. Yang, E. Cheng, W. Hancock, M. Suthanthiran
Differential regulation of positive or negative costimulatory molecules during acute rejection of human renal allografts
C. Afaneh, M. Lubetzky, T. Muthukumar, R. Ding, S. Seshan, C. Snopkowski, V. Sharma, D. Dadhania, M. Suthanthiran
MicroRNA Expression Signatures Distinguish Human Renal Allografts with Interstitial Fibrosis/Tubular atrophy from Normal Allografts
T. Muthukumar, F. Mueller, D. Anglicheau, V. Sharma, R. Ding, D. Dadhania, M. Suthanthiran
Development of a New Strategy for Minimizing Islet Cell Mass in Type 1 Diabetic Recipients: Diannexin Reduces Proapoptotic Bid, Promotes Anti-inflammatory Interleukin-10 and Improves Early Graft Function in the Marginal Islet Mass Transplantation Model
E. Cheng, H. Yang, V. Sharma, M. Lagman, D. Leeser, M. Suthanthiran
CONTACT US
Nephrology and Hypertension
Manikkam Suthanthiran, MD, Chief
Anita Mesi, MBA, Administrator
Room: S-829
Tel: (212) 746-4430
Fax: (212) 746-6894
[email protected]
CLINICAL TRIALS
Click here to view Nephrology and Hypertension Clinical Trials